• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

AECOPD 患者的凝血功能障碍及其与感染和高碳酸血症的关系。

Coagulation dysfunction in patients with AECOPD and its relation to infection and hypercapnia.

机构信息

Department of Respiratory and Critical Care Medicine, Affiliated Provincial Hospital, Anhui Medical University, Hefei, China.

Department of Respiratory and Critical Care Medicine, Affiliated First Hospital, University of Science and Technology of China, Hefei, China.

出版信息

J Clin Lab Anal. 2021 Apr;35(4):e23733. doi: 10.1002/jcla.23733. Epub 2021 Mar 25.

DOI:10.1002/jcla.23733
PMID:33764623
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8059715/
Abstract

BACKGROUND

Patients with chronic obstructive pulmonary disease (COPD) often have coagulation abnormalities. However, the factors that lead to coagulation dysfunction in acute exacerbation of COPD (AECOPD) remain insufficiently explored. This study aimed to investigate the factors affecting coagulation status in patients with COPD and their influence on thrombosis.

METHODS

Data of COPD patients, including 135 cases in acute exacerbation stage and 44 cases in stable stage from Nov 2016 to Nov 2019 in our hospital, were collected. Healthy people (n = 135) were enrolled as the controls. The coagulation parameters, blood gas indexes and blood routine examination results were collected and analyzed.

RESULTS

White blood count (WBC), neutrophil count, neutrophil percentage (N%), platelet (PLT), prothrombin time (PT), international normalized ratio (INR), fibrinogen (FIB), and activated partial thromboplastin time (APTT) increased, plasma thrombin time (TT) decreased in AECOPD group compared with the control group. In AECOPD group, PT, APTT, and FIB were positively correlated with neutrophils and C-reaction protein levels. PT was positively correlated with PCO2 and negatively with pH. Thrombosis was observed in five acute exacerbation and three stable stage COPD patients.

CONCLUSIONS

Patients with AECOPD presented abnormal coagulation status, which was correlated to infection and hypercapnia and might be potentially the risk factor of thrombosis.

摘要

背景

慢性阻塞性肺疾病(COPD)患者常伴有凝血异常。然而,导致 COPD 急性加重(AECOPD)时凝血功能障碍的因素仍未得到充分探索。本研究旨在探讨影响 COPD 患者凝血状态的因素及其对血栓形成的影响。

方法

收集了我院 2016 年 11 月至 2019 年 11 月期间的 135 例急性加重期 COPD 患者和 44 例稳定期 COPD 患者的数据,同时纳入了 135 例健康人作为对照组。收集并分析了凝血参数、血气指标和血常规检查结果。

结果

与对照组相比,AECOPD 组的白细胞计数(WBC)、中性粒细胞计数、中性粒细胞百分比(N%)、血小板(PLT)、凝血酶原时间(PT)、国际标准化比值(INR)、纤维蛋白原(FIB)和活化部分凝血活酶时间(APTT)升高,血浆凝血酶时间(TT)降低。AECOPD 组中 PT、APTT 和 FIB 与中性粒细胞和 C 反应蛋白水平呈正相关。PT 与 PCO2 呈正相关,与 pH 值呈负相关。在 5 例急性加重期和 3 例稳定期 COPD 患者中观察到血栓形成。

结论

AECOPD 患者存在异常的凝血状态,与感染和高碳酸血症有关,可能是血栓形成的潜在危险因素。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8430/8059715/ace57632fffb/JCLA-35-e23733-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8430/8059715/ace57632fffb/JCLA-35-e23733-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8430/8059715/ace57632fffb/JCLA-35-e23733-g001.jpg

相似文献

1
Coagulation dysfunction in patients with AECOPD and its relation to infection and hypercapnia.AECOPD 患者的凝血功能障碍及其与感染和高碳酸血症的关系。
J Clin Lab Anal. 2021 Apr;35(4):e23733. doi: 10.1002/jcla.23733. Epub 2021 Mar 25.
2
Correlation of Coagulation Dysfunction with Infection and Hypercapnia in Acute Exacerbation of COPD Patients.慢性阻塞性肺疾病(COPD)急性加重期患者凝血功能障碍与感染及高碳酸血症的相关性
Infect Drug Resist. 2023 Aug 18;16:5387-5394. doi: 10.2147/IDR.S421925. eCollection 2023.
3
Evaluating the clinical role of fibrinogen, D-dimer, mean platelet volume in patients with acute exacerbation of COPD.评估纤维蛋白原、D-二聚体、平均血小板体积在 COPD 急性加重患者中的临床作用。
Heart Lung. 2023 Jan-Feb;57:54-58. doi: 10.1016/j.hrtlng.2022.08.013. Epub 2022 Aug 31.
4
Effect of urban air pollution on CRP and coagulation: a study on inpatients with acute exacerbation of chronic obstructive pulmonary disease.城市空气污染对 CRP 和凝血的影响:一项关于慢性阻塞性肺疾病急性加重住院患者的研究。
BMC Pulm Med. 2021 Sep 18;21(1):296. doi: 10.1186/s12890-021-01650-z.
5
Biomarkers of Prothrombotic State and Risk Assessment of Exacerbations in Patients with Chronic Obstructive Pulmonary Disease.慢性阻塞性肺疾病患者血栓前状态的生物标志物及加重风险评估。
Int J Chron Obstruct Pulmon Dis. 2024 Oct 11;19:2273-2283. doi: 10.2147/COPD.S466563. eCollection 2024.
6
Decreased CD34+ cell number is correlated with cardiac dysfunction in patients with acute exacerbation of COPD.慢性阻塞性肺疾病急性加重患者中CD34+细胞数量减少与心脏功能障碍相关。
Heart Lung Circ. 2014 Sep;23(9):875-82. doi: 10.1016/j.hlc.2014.03.008. Epub 2014 Mar 16.
7
Neutrophil CD64 as a Marker of Bacterial Infection in Acute Exacerbations of Chronic Obstructive Pulmonary Disease.中性粒细胞CD64作为慢性阻塞性肺疾病急性加重期细菌感染的标志物
Immunol Invest. 2016 Aug;45(6):490-503. doi: 10.1080/08820139.2016.1177540. Epub 2016 May 25.
8
[Analysis of the factors associated with abnormal coagulation and prognosis
 in patients with non-small cell lung cancer].[非小细胞肺癌患者凝血异常及预后相关因素分析]
Zhongguo Fei Ai Za Zhi. 2014 Nov;17(11):789-96. doi: 10.3779/j.issn.1009-3419.2014.11.04.
9
Progranulin is a novel biomarker for predicting an acute exacerbation of chronic obstructive pulmonary disease.颗粒蛋白前体是预测慢性阻塞性肺疾病急性加重的一种新型生物标志物。
Clin Respir J. 2018 Oct;12(10):2525-2533. doi: 10.1111/crj.12952. Epub 2018 Sep 23.
10
Long non-coding RNA PVT1, a novel biomarker for chronic obstructive pulmonary disease progression surveillance and acute exacerbation prediction potentially through interaction with microRNA-146a.长链非编码RNA PVT1,一种可能通过与微小RNA-146a相互作用来监测慢性阻塞性肺疾病进展和预测急性加重的新型生物标志物。
J Clin Lab Anal. 2020 Aug;34(8):e23346. doi: 10.1002/jcla.23346. Epub 2020 Apr 27.

引用本文的文献

1
Clinical characteristics, clinical laboratories, and risk factors of elderly patients with chronic obstructive pulmonary disease complicated with pulmonary embolism.老年慢性阻塞性肺疾病合并肺栓塞患者的临床特征、临床实验室检查及危险因素
Front Med (Lausanne). 2025 May 14;12:1421169. doi: 10.3389/fmed.2025.1421169. eCollection 2025.
2
Predicting Superaverage Length of Stay in COPD Patients with Hypercapnic Respiratory Failure Using Machine Learning.使用机器学习预测慢性阻塞性肺疾病合并高碳酸血症呼吸衰竭患者的超长住院时间
J Inflamm Res. 2025 May 8;18:5993-6008. doi: 10.2147/JIR.S511092. eCollection 2025.
3
Constructing an early warning model for elderly sepsis patients based on machine learning.

本文引用的文献

1
The effect of COPD on the incidence and mortality of hospitalized patients with pulmonary embolism: A nationwide population-based study (2016-2018).慢性阻塞性肺疾病对住院肺栓塞患者发病率和死亡率的影响:一项全国范围内基于人群的研究(2016-2018 年)。
Eur J Intern Med. 2021 Feb;84:18-23. doi: 10.1016/j.ejim.2020.11.009. Epub 2020 Nov 26.
2
Coagulation markers as predictors for clinical events in COPD.凝血标志物可预测 COPD 临床事件。
Respirology. 2021 Apr;26(4):342-351. doi: 10.1111/resp.13971. Epub 2020 Nov 9.
3
Acute exacerbations of COPD are associated with a prothrombotic state through platelet-monocyte complexes, endothelial activation and increased thrombin generation.
基于机器学习构建老年脓毒症患者预警模型。
Sci Rep. 2025 Mar 27;15(1):10580. doi: 10.1038/s41598-025-95604-8.
4
Proteomic Blood Profiles Obtained by Totally Blind Biological Clustering in Stable and Exacerbated COPD Patients.稳定期和加重期 COPD 患者的完全盲法生物聚类获得的蛋白质组学血液谱。
Cells. 2024 May 17;13(10):866. doi: 10.3390/cells13100866.
5
A Diagnostic Nomogram for Predicting Hypercapnic Respiratory Failure in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease.用于预测慢性阻塞性肺疾病急性加重患者高碳酸血症性呼吸衰竭的诊断列线图。
Int J Chron Obstruct Pulmon Dis. 2024 May 18;19:1079-1091. doi: 10.2147/COPD.S454558. eCollection 2024.
6
Acute Exacerbation of Chronic Obstructive Pulmonary Disease Due to Carbapenem-Resistant -Induced Pneumonia: Clinical Features and Prognostic Factors.耐碳青霉烯类肺炎导致的慢性阻塞性肺疾病急性加重:临床特征及预后因素
Int J Chron Obstruct Pulmon Dis. 2024 Mar 7;19:683-693. doi: 10.2147/COPD.S447905. eCollection 2024.
7
Thrombelastography and Conventional Coagulation Markers in Chronic Obstructive Pulmonary Disease: A Prospective Paired-Measurements Study Comparing Exacerbation and Stable Phases.血栓弹力描记术和常规凝血标志物在慢性阻塞性肺疾病中的应用:一项比较加重期和稳定期的前瞻性配对测量研究。
Int J Mol Sci. 2024 Feb 8;25(4):2051. doi: 10.3390/ijms25042051.
8
Correlation of Coagulation Dysfunction with Infection and Hypercapnia in Acute Exacerbation of COPD Patients.慢性阻塞性肺疾病(COPD)急性加重期患者凝血功能障碍与感染及高碳酸血症的相关性
Infect Drug Resist. 2023 Aug 18;16:5387-5394. doi: 10.2147/IDR.S421925. eCollection 2023.
9
Galectin-3 as a Marker for Increased Thrombogenicity in COVID-19.半乳糖凝集素-3 作为 COVID-19 血栓形成风险增加的标志物。
Int J Mol Sci. 2023 Apr 22;24(9):7683. doi: 10.3390/ijms24097683.
10
Analysis of the Clinical Efficacy and Molecular Mechanism of Xuefu Zhuyu Decoction in the Treatment of COPD Based on Meta-Analysis and Network Pharmacology.基于荟萃分析和网络药理学探讨血府逐瘀汤治疗 COPD 的临床疗效及分子机制
Comput Math Methods Med. 2022 Nov 26;2022:2615580. doi: 10.1155/2022/2615580. eCollection 2022.
COPD 急性加重与血小板-单核细胞复合物、内皮细胞激活和凝血酶生成增加有关,导致促凝状态。
Respir Med. 2020 Sep;171:106094. doi: 10.1016/j.rmed.2020.106094. Epub 2020 Jul 25.
4
Coagulation dysfunction is associated with severity of COVID-19: A meta-analysis.凝血功能障碍与 COVID-19 严重程度相关:一项荟萃分析。
J Med Virol. 2021 Feb;93(2):962-972. doi: 10.1002/jmv.26336. Epub 2020 Oct 14.
5
Prevalence and attributable health burden of chronic respiratory diseases, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017.1990-2017 年慢性呼吸道疾病的流行情况和可归因健康负担:2017 年全球疾病负担研究的系统分析。
Lancet Respir Med. 2020 Jun;8(6):585-596. doi: 10.1016/S2213-2600(20)30105-3.
6
Nebulized heparin and salbutamol versus salbutamol alone in acute exacerbations of chronic obstructive pulmonary disease requiring mechanical ventilation: a double-blind randomized controlled trial.雾化肝素和沙丁胺醇与单独使用沙丁胺醇治疗需要机械通气的慢性阻塞性肺疾病急性加重:一项双盲随机对照试验。
Korean J Anesthesiol. 2020 Dec;73(6):509-517. doi: 10.4097/kja.19418. Epub 2020 Feb 28.
7
Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia.异常的凝血参数与新型冠状病毒肺炎患者的预后不良有关。
J Thromb Haemost. 2020 Apr;18(4):844-847. doi: 10.1111/jth.14768. Epub 2020 Mar 13.
8
Pulmonary Thrombosis: A Clinical Pathological Entity Distinct from Pulmonary Embolism?肺血栓栓塞症:一种与肺栓塞不同的临床病理实体?
Semin Thromb Hemost. 2019 Nov;45(8):778-783. doi: 10.1055/s-0039-1696942. Epub 2019 Sep 19.
9
Forecasting life expectancy, years of life lost, and all-cause and cause-specific mortality for 250 causes of death: reference and alternative scenarios for 2016-40 for 195 countries and territories.预测 250 种死因的预期寿命、损失的生命年数以及全因和特定死因死亡率:2016-2040 年 195 个国家和地区的参考和替代情景。
Lancet. 2018 Nov 10;392(10159):2052-2090. doi: 10.1016/S0140-6736(18)31694-5. Epub 2018 Oct 16.
10
The prevalence and risk factors of venous thromboembolism in hospitalized patients with acute exacerbation of chronic obstructive pulmonary disease.慢性阻塞性肺疾病急性加重期住院患者静脉血栓栓塞症的患病率及危险因素
Clin Respir J. 2018 Nov;12(11):2573-2580. doi: 10.1111/crj.12959. Epub 2018 Oct 22.